Arlington, MA, United States of America

Randi Michelle Kotlar

USPTO Granted Patents = 7 

Average Co-Inventor Count = 9.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Randi Michelle Kotlar: Innovator in Genome Modulation

Introduction

Randi Michelle Kotlar is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of genome modulation, holding a total of 7 patents. Her work focuses on innovative methods and compositions that alter genomes, which has important implications for genetic research and therapy.

Latest Patents

Among her latest patents are "Methods and compositions for modulating a genome" and "CFTR-modulating compositions and methods." The first patent discloses novel compositions, systems, and methods for altering a genome at one or more locations in a host cell, tissue, or subject, both in vivo and in vitro. This invention features compositions and methods for inserting, altering, or deleting sequences of interest in a host genome. The second patent provides compositions, systems, and methods for targeting, editing, modifying, or manipulating a host cell's genome, particularly for treating cystic fibrosis in subjects with the F508del mutation.

Career Highlights

Randi is currently associated with Flagship Pioneering Innovations Vi, LLC, where she continues to advance her research in genome modulation. Her innovative approaches have positioned her as a key figure in the biotechnology sector.

Collaborations

Randi has collaborated with notable professionals in her field, including Robert Charles Altshuler and Anne Helen Bothmer, who contribute to her research endeavors.

Conclusion

Randi Michelle Kotlar's work in genome modulation exemplifies the innovative spirit of modern science. Her patents and ongoing research are paving the way for advancements in genetic therapies and treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…